<ARTICLE> 5 <LEGEND> This schedule contains summary financial information extracted from unaudited financial statements contained in Form 10-Q for the Quarter ending September 30, 1995 and is qualified in its entirety by reference to such financial statements. </LEGEND> <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> DEC-31-1995 <PERIOD-END> SEP-30-1995 <CASH> 1,394,561 <SECURITIES> 0 <RECEIVABLES> 1,369,333 <ALLOWANCES> 119,178 <INVENTORY> 455,539 <CURRENT-ASSETS> 3,258,317 <PP&E> 3,581,747 <DEPRECIATION> 2,199,616 <TOTAL-ASSETS> 6,295,607 <CURRENT-LIABILITIES> 1,191,218 <BONDS> 0 <COMMON> 12,151,153 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <OTHER-SE> (7,578,900) <TOTAL-LIABILITY-AND-EQUITY> 6,295,607 <SALES> 8,051,144 <TOTAL-REVENUES> 8,051,144 <CGS> 6,050,692 <TOTAL-COSTS> 6,050,692 <OTHER-EXPENSES> 2,156,896<F1> <LOSS-PROVISION> 819 <INTEREST-EXPENSE> 40,771 <INCOME-PRETAX> (162,164) <INCOME-TAX> 0 <INCOME-CONTINUING> (162,164) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (162,164) <EPS-PRIMARY> (.03) <EPS-DILUTED> (.03) <FN> <F1>Other expenses include $1,460,721 in general and administrative expense and $696,175 in research and development expense. </FN>